China grants its highest-ever antitrust damages award
A court in Nanjing has awarded Yangtze River Pharmaceutical Group nearly €9 million for successfully showing that suppliers of an active pharmaceutical ingredient for its antihistamine tablet abused their dominance.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.